Results
1 -
10 of
25Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin, Cancer Chemotherapy and Pharmacology DNA-Minor Groove Binding Anticancer Agents, Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development Antitumor Drugs and Yeast Cell Cycle Checkpoints, Genomic Instability and Immortality in Cancer Modified 2-Tumor (L1210, Colon 38) Assay to Screen for Solid Tumor Selective Agents, Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development Sequence-Selective Groove Binders, Cancer Therapeutics Immunotoxins and Antibody-Drug Conjugates for Cancer Treatment, Biomedical Aspects of Drug Targeting Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065, Investigational New Drugs Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effects, Cancer Chemotherapy and Pharmacology In vitro evaluation of a novel chemotherapeutic agent, adozelesin, in gynecologic-cancer cell lines, Cancer Chemotherapy and Pharmacology Preclinical pharmacology of bizelesin, a potent bifunctional analog of the DNA-binding antibiotic CC-1065, Cancer Chemotherapy and Pharmacology